Using ctDNA to Guide Treatment Decisions for Stage III Gastric Cancer

NCT06939439 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

416

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer Stage III

Interventions

DRUG: Tislelizumab + SOX Chemotherapy
DRUG: SOX Chemotherapy

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]